AngioDynamics
ANGO
156 hedge funds and large institutions have $936M invested in AngioDynamics in 2021 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 47 increasing their positions, 70 reducing their positions, and 18 closing their positions.
3% less funds holding
Funds holding: 161 → 156 (-5)
3.8% less ownership
Funds ownership: 97.27% → 93.47% (-3.8%)
7% less capital invested
Capital invested by funds: $1.01B → $936M (-$70.8M)
28% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 18
33% less repeat investments, than reductions
Existing positions increased: 47 | Existing positions reduced: 70
87% less call options, than puts
Call options by funds: $266K | Put options by funds: $2.12M
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
+$32.8M |
| 2 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$19.6M |
| 3 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$6.49M |
| 4 |
Goldman Sachs
New York
|
+$6.08M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$2.88M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$26.7M |
| 2 |
Wells Fargo
San Francisco,
California
|
-$19.5M |
| 3 |
Millennium Management
New York
|
-$10M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$9.62M |
| 5 |
Nordea Investment Management
Stockholm,
Sweden
|
-$6.6M |
ANGO Hedge Fund Activity: Q3 2021 in Review
156 of the 5,728 institutional investors tracked by Wall St. Rank reported a position in AngioDynamics (ANGO) for Q3 2021, worth a combined $936M — down 7% from $1.01B a quarter earlier.
Sellers outnumbered buyers: 18 funds closed out of ANGO and 13 opened new positions — a net loss of 5 holders — while 70 trimmed existing stakes and 47 added.
The largest buyer was Polar Capital Holdings, adding an estimated $32.8M. The largest seller was Fidelity Investments, cutting an estimated $26.7M.
- 156 institutional investors held AngioDynamics (ANGO) as of Q3 2021, down from 161 in Q2 2021.
- Funds reported $936M of AngioDynamics stock for Q3 2021, down 7% quarter-over-quarter.
- 13 funds opened new AngioDynamics positions in Q3 2021 and 18 closed out, a net change of -5 holders.
- The largest AngioDynamics buyer in Q3 2021 was Polar Capital Holdings, an estimated $32.8M added.
- The largest AngioDynamics seller in Q3 2021 was Fidelity Investments, an estimated $26.7M sold.
Based on aggregated 13F filings for Q3 2021.